Drug Database
N04BC04 ropinirole
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Adartrel 0.25, 0.5, and 2.0 mg film-coated Tablets
- POM Ipinnia XL Prolonged-Release Tablets
- POM Ralnea XL 2 mg prolonged-release tablets
- POM Ralnea XL 4 mg prolonged-release tablets
- POM Ralnea XL 8 mg prolonged-release tablets
- POM Raponer XL 2mg Prolonged-release Tablets
- POM Raponer XL 4mg Prolonged-release Tablets
- POM Raponer XL 8mg Prolonged-release Tablets
- POM Repinex XL 2mg prolonged-release tablets
- POM Repinex XL 4mg prolonged-release tablets
- POM Repinex XL 8mg prolonged-release tablets
- POM Requip 0.25 mg Tablets
- POM Requip 1 mg Tablets
- POM Requip 2 mg Tablets
- POM Requip 5 mg Tablets
- POM Requip XL prolonged-release tablets
- POM Ropilynz XL 2 mg prolonged-release tablets
- POM Ropilynz XL 4 mg prolonged-release tablets
- POM Ropilynz XL 8 mg prolonged-release tablets
- POM Ropinirole 0.25 mg film-coated tablets
- POM Ropinirole 0.5 mg film-coated tablets
- POM Ropinirole 0.5 mg Film-coated Tablets
- POM Ropinirole 1 mg Film-coated Tablets
- POM Ropinirole 1 mg film-coated tablets.
- POM Ropinirole 2 mg Film-coated Tablets
- POM Ropinirole 2 mg film-coated tablets.
- POM Ropinirole 5 mg film-coated tablets.
- POM Ropinirole Mylan XL 2 mg prolonged-release tablets
- POM Ropinirole Mylan XL 4 mg prolonged-release tablets
- POM Ropinirole XL 8 mg prolonged-release tablets
- POM ROPIQUAL XL 2 mg prolonged-release tablets
- POM ROPIQUAL XL 4 mg prolonged-release tablets
- POM ROPIQUAL XL 8 mg prolonged-release tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).